Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens
2005
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Weaning from mechanical ventilation
2007 Standout
Recommendations for the practice of echocardiography in infective endocarditis
2010
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia
2010
Suggestions for managing pyogenic (non-tuberculous) discitis in adults
2007
Community-acquired pneumonia
2003
Management of infections due to resistant enterococci: a review of therapeutic options
1997
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996–2004): report to the Joint MRSA Working Party (Subgroup A)
2006
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Enterococci as probiotics and their implications in food safety
2011 Standout
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials
2013
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Treatment Options for Vancomycin- Resistant Enterococcal Infections
2002
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
2012
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Epidemiology of Methicillin‐ResistantStaphylococcus aureus
2008
Successful Treatment of Meningitis Due to Multiply Resistant Enterococcus faecium with a Combination of Intrathecal Teicoplanin and Intravenous Antimicrobial Agents
1994
Update on pulmonary disease due to non-tuberculous mycobacteria
2016
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy
2020 Standout
Selective Use of Blood Cultures in Emergency Department Pneumonia Patients
2007
Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota
2013
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Herpes Zoster
2013 Standout
Aortic valve endocarditis: is there an optimal surgical timing?
2007
Recognition, Management and Prophylaxis of Endocarditis
1997
The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired Pneumonia
2003
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
2010
Nosocomial Bacteremia Due to Enterococcus faecalis without Endocarditis
1992
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Management of multidrug-resistant organisms in health care settings, 2006
2007
Nontuberculous Pulmonary Mycobacteriosis in Denmark
2009
Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London
2012
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Optimizing combination rifampin therapy for staphylococcal osteoarticular infections
2013
Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population
2012
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
2011
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Health‐related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review
2016
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals
2010
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Guidelines for the management of hemophilia
2012 Standout
Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
2007
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of J.L. Schmit being referenced
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients
2008
Changing epidemiology of methicillin-resistant Staphylococcus aureus and effects on cross-transmission in a teaching hospital
2006
Utility of blood cultures in community-acquired pneumonia requiring hospitalization: influence of antibiotic treatment before admission
1999
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
2008
Traitement des infections ostéoarticulaires par clindamycine chez l’adulte
2008
Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital
2001
Efficacy of Teicoplanin for Enterococcal Infections: 63 Cases and Review
1992
[Outcome of cardiac valve ring abscesses after medical treatment: attempt to identify criteria of favorable prognosis].
1996
Étude des spondylodiscites infectieuses au CHU d'Amiens sur une période de 5 ans
2002